Showing results (301-310 of 334) with videos related to
Sort By:
Pageof 34
Journal of Magnetic Resonance Imaging : JMRI|October 2, 2012
Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS-MLPA in patients with glioblastoma multiformeLeonard Sunwoo, Seung Hong Choi, Chul-Kee Park, et al.Cancer Research and Treatment|November 2, 2019
Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)Kihwan Hwang, Tae Min Kim, Chul-Kee Park, et al.International Journal of Cancer|August 3, 2019
Genome-wide investigation of intragenic DNA methylation identifies ZMIZ1 gene as a prognostic marker in glioblastoma and multiple cancer typesDimitrios Mathios, Taeyoung Hwang, Yuanxuan Xia, et al.Oncoimmunology|September 18, 2018
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBMAlice L Hung, Russell Maxwell, Debebe Theodros, et al.Cancer Research and Treatment|July 27, 2016
Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in GlioblastomaYoung-Bem Se, Seung Hyun Kim, Ji Young Kim, et al.Cancer Immunology, Immunotherapy : CII|January 8, 2021
Absolute quantification of tumor-infiltrating immune cells in high-grade glioma identifies prognostic and radiomics valuesA Reum Kim, Kyu Sung Choi, Min-Sung Kim, et al.Genome Medicine|March 14, 2023
Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastomaYoonhee Nam, Harim Koo, Yingxi Yang, et al.Chemical Science|September 3, 2020
Penta-fluorophenol: a Smiles rearrangement-inspired cysteine-selective fluorescent probe for imaging of human glioblastomaJong Min An, Sangrim Kang, Eugene Huh, et al.Journal of Neuro-Oncology|November 6, 2010
Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trialIl Han Kim, Chul-Kee Park, Dae Seog Heo, et al.Cancer Research and Treatment|July 8, 2021
Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study)Grace S Ahn, Kihwan Hwang, Tae Min Kim, et al.Pageof 34